Senseonics Holdings Inc
6L6
Company Profile
Business description
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.
Contact
20451 Seneca Meadows Parkway
GermantownMD20876-7005
USAT: +1 301 515-7260
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
132
Stocks News & Analysis
stocks
Vote in favour of merger for undervalued ASX share
We recommend shareholders vote in favor of its proposed merger.
stocks
Are investors missing the boat on this future ASX leader?
The market is underestimating the clear path to profitability.
stocks
ASX shares plunge but remain undervalued
Shares drop 17% after guidance is revised but we still see value.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,569.10 | 112.30 | 1.33% |
| CAC 40 | 7,623.38 | 148.79 | 1.99% |
| DAX 40 | 20,611.41 | 36.73 | 0.18% |
| Dow JONES (US) | 43,221.55 | 703.27 | 1.65% |
| FTSE 100 | 8,359.19 | 58.06 | 0.70% |
| HKSE | 19,522.89 | 236.82 | 1.23% |
| NASDAQ | 19,511.23 | 466.84 | 2.45% |
| Nikkei 225 | 38,572.60 | 128.02 | 0.33% |
| NZX 50 Index | 13,000.67 | 57.10 | 0.44% |
| S&P 500 | 5,949.91 | 107.00 | 1.83% |
| S&P/ASX 200 | 8,327.00 | 113.70 | 1.38% |
| SSE Composite Index | 3,236.03 | 8.92 | 0.28% |